NASDAQ : TLPH
Talphera, Inc. — Financial statements
Healthcare · Drug Manufacturers - Specialty & Generic · United States
Last price 1.03 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 53.46M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Talphera, Inc. (TLPH) reported revenue of 1.00K USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 1.00K | 28.00K | 651.00K | 378.00K | ||
| Cost of Revenue | 6.70M | 6.03M | 6.72M | 5.55M | 3.34M | 3.01M |
| Gross Profit | -6.70M | -6.00M | -6.72M | -4.89M | -3.34M | -2.63M |
| Selling, General & Admin | 8.04M | 7.48M | 8.53M | 11.99M | 17.01M | 15.49M |
| Operating Expenses | 8.04M | 7.48M | 8.53M | 11.99M | 17.01M | 15.49M |
| Operating Income | -14.75M | -13.48M | -15.25M | -16.89M | -20.35M | -18.12M |
| Interest Expense | -394.00K | -134.00K | -1.12M | -2.19M | ||
| Interest & Investment Income | 625.00K | 436.00K | 679.00K | 1.42M | 1.50M | 3.16M |
| Other Non Operating Income (Expenses) | -954.00K | -1.31M | 1.96M | 5.32M | ||
| EBT Excluding Unusual Items | -15.08M | -14.36M | -13.00M | -10.29M | -19.97M | -17.15M |
| Asset Writedown | -4.95M | |||||
| Other Unusual Items | 84.05M | |||||
| Pretax Income | -15.08M | -14.36M | -13.00M | -10.29M | 59.14M | -17.15M |
| Income Tax Expense | 13.00K | 5.00K | ||||
| Earnings From Continuing Operations | -15.08M | -14.36M | -13.00M | -10.29M | 59.12M | -17.15M |
| Earnings From Discontinued Operations | 73.00K | -8.11M | -11.37M | -17.95M | ||
| Net Income | -15.08M | -14.29M | -13.00M | -18.40M | 47.76M | -35.10M |
| Preferred Dividends & Other Adjustments | 5.43M | |||||
| Net Income to Common | -15.08M | -14.29M | -13.00M | -18.40M | 42.33M | -35.10M |
| Shares Outstanding (Basic) | 63.54M | 42.41M | 25.85M | 14.26M | 7.39M | 5.99M |
| Shares Outstanding (Diluted) | 63.54M | 42.41M | 25.85M | 14.26M | 7.41M | 5.99M |
| EPS (Basic) | -0.24 | -0.34 | -0.50 | -1.29 | 5.73 | -5.86 |
| EPS (Diluted) | -0.24 | -0.34 | -0.50 | -1.29 | 5.72 | -5.86 |
| Free Cash Flow | -12.27M | -11.36M | -12.68M | -17.59M | -28.70M | -31.83M |
| Free Cash Flow Per Share | -0.19 | -0.27 | -0.49 | -1.23 | -3.87 | -5.31 |
| Operating Margin | -1,474,700.00% | -48,157.14% | -2,594.32% | -4,792.59% | ||
| Profit Margin | -1,507,600.00% | -51,035.71% | -2,825.96% | -9,285.45% | ||
| Free Cash Flow Margin | -1,227,000.00% | -40,585.71% | -2,702.30% | -8,420.37% | ||
| EBITDA | -15.16M | -16.79M | -20.17M | -16.14M | ||
| D&A For EBITDA | 96.00K | 96.00K | 182.00K | 1.97M | ||
| EBIT | -14.75M | -13.48M | -15.25M | -16.89M | -20.35M | -18.12M |
| Effective Tax Rate | 0.02% | |||||
| Revenue as Reported | 378.00K |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 742.00K | 5.89M | 8.86M | 5.72M | 15.28M | 7.66M |
| Short-Term Investments | 16.33M | 14.49M | 3.66M | 495.00K | 38.97M | |
| Cash & Short-Term Investments | 17.08M | 20.38M | 8.86M | 9.38M | 15.77M | 46.63M |
| Prepaid Expenses | 911.00K | 519.00K | 554.00K | 2.19M | 1.86M | 2.01M |
| Restricted Cash | 5.00M | |||||
| Other Current Assets | 1.93M | 1.85M | ||||
| Total Current Assets | 17.99M | 20.90M | 9.42M | 11.58M | 24.57M | 50.49M |
| Property, Plant & Equipment | 5.18M | |||||
| Long-Term Deferred Charges | 8.82M | 8.82M | 8.82M | 8.82M | 8.82M | |
| Other Long-Term Assets | 14.10M | 22.23M | ||||
| Total Assets | 26.81M | 29.72M | 18.24M | 20.39M | 47.49M | 77.89M |
| Accounts Payable | 387.00K | 544.00K | 670.00K | 1.34M | 1.26M | 917.00K |
| Accrued Expenses | 3.15M | 2.62M | 1.25M | 2.44M | 2.53M | 3.43M |
| Current Portion of Long-Term Debt | 5.36M | 8.33M | ||||
| Current Portion of Leases | 182.00K | |||||
| Other Current Liabilities | 650.00K | 650.00K | 723.00K | 731.00K | 4.62M | 5.65M |
| Total Current Liabilities | 4.19M | 3.81M | 2.65M | 4.51M | 13.77M | 18.51M |
| Long-Term Debt | 6.50M | 6.50M | 6.53M | 90.30M | ||
| Long-Term Leases | 101.00K | |||||
| Other Long-Term Liabilities | 1.71M | 2.38M | 1.06M | 1.78M | 11.90M | 4.88M |
| Total Liabilities | 12.40M | 12.68M | 10.23M | 6.29M | 25.67M | 113.79M |
| Common Stock | 52.00K | 49.00K | 17.00K | 17.00K | 8.00K | 7.00K |
| Additional Paid-In Capital | 492.74M | 488.51M | 465.21M | 458.31M | 447.63M | 437.68M |
| Retained Earnings | -478.39M | -471.52M | -457.23M | -444.23M | -425.83M | -473.58M |
| Shareholders' Equity | 14.41M | 17.04M | 8.00M | 14.11M | 21.81M | -35.89M |
| Total Liabilities & Equity | 26.81M | 29.72M | 18.24M | 20.39M | 47.49M | 77.89M |
| Total Debt | 6.50M | 6.50M | 6.53M | 5.36M | 98.91M | |
| Net Cash (Debt) | 10.58M | 13.88M | 2.34M | 9.38M | 10.41M | -52.28M |
| Net Cash Per Share | 0.17 | 0.33 | 0.09 | 0.66 | 1.41 | -8.72 |
| Filing Date Shares Outstanding | 51.91M | 50.05M | 17.10M | 16.97M | 10.92M | 7.35M |
| Total Common Shares Outstanding | 51.91M | 49.33M | 17.03M | 16.95M | 8.24M | 6.84M |
| Working Capital | 13.80M | 17.09M | 6.77M | 7.06M | 10.80M | 31.98M |
| Book Value Per Share | 0.28 | 0.35 | 0.47 | 0.83 | 2.65 | -5.25 |
| Tangible Book Value | 14.41M | 17.04M | 8.00M | 14.11M | 21.81M | -35.89M |
| Tangible Book Value Per Share | 0.28 | 0.35 | 0.47 | 0.83 | 2.65 | -5.25 |
| Machinery | 3.61M | |||||
| Construction In Progress | 4.87M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -15.08M | -14.29M | -13.00M | -18.40M | 47.76M | -35.10M |
| Depreciation & Amortization | 96.00K | 182.00K | 1.97M | |||
| Asset Writedown & Restructuring Costs | 4.95M | |||||
| Loss (Gain) From Sale of Investments | -379.00K | -142.00K | -121.00K | |||
| Stock-Based Compensation | 794.00K | 699.00K | 989.00K | 1.71M | 2.64M | 4.61M |
| Other Operating Activities | 953.00K | 1.29M | -323.00K | -6.01M | -84.18M | -1.69M |
| Change in Accounts Receivable | -149.00K | 475.00K | ||||
| Change in Inventory | 61.00K | -107.00K | -295.00K | |||
| Change in Accounts Payable | -529.00K | -208.00K | -671.00K | -575.00K | 551.00K | 111.00K |
| Change in Unearned Revenue | -29.00K | -86.00K | 1.19M | |||
| Change in Other Net Operating Assets | 1.97M | 1.29M | 447.00K | -998.00K | -1.60M | -1.28M |
| Operating Cash Flow | -12.27M | -11.36M | -12.68M | -17.49M | -28.33M | -30.00M |
| Capital Expenditures | -100.00K | -364.00K | -1.83M | |||
| Sale of Property, Plant & Equipment | 2.72M | |||||
| Cash Acquisitions | -1.69M | -821.00K | ||||
| Investment in Securities | -15.96M | -14.35M | 3.78M | -3.15M | 38.50M | -23.48M |
| Investing Cash Flow | -15.96M | -14.35M | 3.78M | -528.00K | 36.45M | -26.12M |
| Long-Term Debt Repaid | -5.42M | -8.43M | -8.83M | |||
| Net Debt Issued (Repaid) | -5.42M | -8.43M | -8.83M | |||
| Issuance of Common Stock | 17.00K | 27.00K | 8.88M | 8.06M | 50.60M | |
| Repurchase of Common Stock | -544.00K | -58.00K | -249.00K | |||
| Other Financing Activities | 22.72M | 22.72M | 12.02M | |||
| Financing Cash Flow | 22.18M | 22.74M | 12.04M | 3.47M | -507.00K | 41.51M |
| Net Cash Flow | -6.05M | -2.97M | 3.14M | -14.55M | 7.61M | -14.61M |
| Free Cash Flow | -12.27M | -11.36M | -12.68M | -17.59M | -28.70M | -31.83M |
| Free Cash Flow Margin | -1,227,000.00% | -40,585.71% | -2,702.30% | -8,420.37% | ||
| Free Cash Flow Per Share | -0.19 | -0.27 | -0.49 | -1.23 | -3.87 | -5.31 |
| Levered Free Cash Flow | -6.87M | -6.53M | -9.01M | -6.23M | -17.48M | -6.31M |
| Unlevered Free Cash Flow | -6.87M | -6.53M | -8.77M | -6.14M | -16.79M | -4.94M |
| Cash Interest Paid | 119.00K | 824.00K | 1.59M | |||
| Cash Income Tax Paid | 13.00K | 5.00K | ||||
| Change in Working Capital | 1.44M | 1.08M | -224.00K | -1.54M | -1.39M | 203.00K |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 53.20M | 53.13M | 8.93M | 12.46M | 18.53M | 76.65M |
| Enterprise Value | 42.63M | 38.34M | 4.34M | -929.08K | 15.39M | 134.32M |
| Last Close Price | 1.03 | 1.14 | 0.52 | 0.73 | 2.26 | 11.20 |
| PE Ratio | 0.44 | |||||
| PS Ratio | 53,462.97 | 1,897.68 | 19.14 | 202.77 | ||
| PB Ratio | 3.71 | 3.12 | 1.11 | 0.88 | 0.85 | -2.13 |
| P/TBV Ratio | 3.71 | 3.12 | 1.11 | 0.88 | 0.85 | |
| EV/Sales Ratio | 42,885.97 | 1,369.46 | 355.35 | |||
| Debt / Equity Ratio | 0.45 | 0.38 | 0.82 | 0.25 | -2.76 | |
| Net Debt / Equity Ratio | -0.73 | -0.81 | -0.29 | -0.67 | -0.48 | -1.46 |
| Net Debt / EBITDA Ratio | 0.15 | 0.56 | 0.52 | -3.24 | ||
| Net Debt / FCF Ratio | 0.86 | 1.22 | 0.18 | 0.53 | 0.36 | -1.64 |
| Asset Turnover | 0.00 | 0.00 | 0.02 | 0.01 | ||
| Quick Ratio | 4.08 | 5.35 | 3.35 | 2.08 | 1.15 | 2.52 |
| Current Ratio | 4.29 | 5.49 | 3.56 | 2.57 | 1.78 | 2.73 |
| Return on Equity (ROE) | -143.36% | -114.74% | -117.65% | -57.28% | ||
| Return on Assets (ROA) | -42.55% | -35.15% | -49.35% | -31.10% | -20.29% | -15.71% |
| Return on Invested Capital (ROIC) | -383.14% | -305.83% | -293.62% | -209.40% | -57.49% | -33.53% |
| Return on Capital Employed (ROCE) | -65.20% | -52.00% | -97.80% | -106.30% | -60.40% | -30.50% |
| Earnings Yield | -23.15% | -26.89% | -145.70% | -147.65% | 257.75% | -45.79% |
| FCF Yield | -22.95% | -21.39% | -142.11% | -141.19% | -154.88% | -41.53% |
| Buyback Yield / Dilution | -124.33% | -64.09% | -81.20% | -92.57% | -23.59% | -40.59% |